Correlation Between Cullinan Oncology and Talaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Talaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Talaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cullinan Oncology LLC and Talaris Therapeutics, you can compare the effects of market volatilities on Cullinan Oncology and Talaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Talaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Talaris Therapeutics.
Diversification Opportunities for Cullinan Oncology and Talaris Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cullinan and Talaris is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Talaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talaris Therapeutics and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Talaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talaris Therapeutics has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Talaris Therapeutics go up and down completely randomly.
Pair Corralation between Cullinan Oncology and Talaris Therapeutics
If you would invest 298.00 in Talaris Therapeutics on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Talaris Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Cullinan Oncology LLC vs. Talaris Therapeutics
Performance |
| Timeline |
| Cullinan Oncology LLC |
| Talaris Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cullinan Oncology and Talaris Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cullinan Oncology and Talaris Therapeutics
The main advantage of trading using opposite Cullinan Oncology and Talaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Talaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talaris Therapeutics will offset losses from the drop in Talaris Therapeutics' long position.| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals |
| Talaris Therapeutics vs. Edgewise Therapeutics | Talaris Therapeutics vs. Adicet Bio | Talaris Therapeutics vs. Cullinan Oncology LLC | Talaris Therapeutics vs. Vor Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |